Patents Assigned to ENZYMATICA AB
  • Trypsin isoforms and their use
    Patent number: 11918674
    Abstract: The present invention relates to the novel trypsin ZT isoforms. In particular, the invention relates to the use of trypsin ZT isoforms in medical devices, pharmaceuticals and cosmetics.
    Type: Grant
    Filed: October 15, 2021
    Date of Patent: March 5, 2024
    Assignee: ENZYMATICA AB
    Inventors: Agusta Gudmundsdottir, Asgeir Asgeirsson, Bjarki Stefansson
  • Combination therapies
    Patent number: 11338021
    Abstract: The invention provides combination therapy for use in treating a bacterial biofilm in a subject comprising (a) a polypeptide having serine protease activity and (b) one or more antibiotic compounds. Also provided are compositions and methods of use of the same.
    Type: Grant
    Filed: July 22, 2016
    Date of Patent: May 24, 2022
    Assignee: ENZYMATICA AB
    Inventors: Ágústa GuÐmundsdóttir, Reynir Scheving
  • NOVEL TRYPSIN ISOFORMS AND THEIR USE
    Publication number: 20220062148
    Abstract: The present invention relates to the novel trypsin ZT isoforms. In particular, the invention relates to the use of trypsin ZT isoforms in medical devices, pharmaceuticals and cosmetics.
    Type: Application
    Filed: October 15, 2021
    Publication date: March 3, 2022
    Applicant: ENZYMATICA AB
    Inventors: Agusta GUDMUNDSDOTTIR, Asgeir ASGEIRSSON, Bjarki STEFANSSON
  • Trypsin isoforms and their use
    Patent number: 11179311
    Abstract: The present invention relates to the novel trypsin ZT isoforms. In particular, the invention relates to the use of trypsin ZT isoforms in medical devices, pharmaceuticals and cosmetics.
    Type: Grant
    Filed: July 22, 2016
    Date of Patent: November 23, 2021
    Assignee: ENZYMATICA AB
    Inventors: Agusta Gudmundsdottir, Asgeir Asgeirsson, Bjarki Stefansson